BSYI Financials: BioSyntech Inc AI Analysis

Home

Stock

BSYI

Financials

BSYI Financial

BioSyntech Inc

0%

$0

At close: Mar 24, 16:00:00 GMT-4

0%

$0

Pre-market: Mar 25, 05:42:24 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BSYI?

BioSyntech, Inc. Engages in the development of bio-therapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company is headquartered in Laval, Quebec and currently employs 20 full-time employees. The firm is developing biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. The firm's platform technology is a family of hydrogels called BST-Gel, some of which are liquid at low temperature and solid at human body temperature. These gels can be injected or applied to a specific local site and offers properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds and provide the benefit of avoiding invasive surgery. The firm's lead, late-stage product, BST-CarGel is undergoing an international pivotal trial.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

BSYI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	03/31/2009	03/31/2008	03/31/2007	03/31/2006	03/31/2005
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	2	3	3	3	2	2
Research & Development	3	5	6	4	3	1
Operating Expenses	6	7	9	8	6	4
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-12	-12	-9	-8	-6	-5
Income Tax Expense	0	0	0	0	0	0
Net Income	-12	-12	-9	-8	-6	-5
Net Income Growth	0%	33%	13%	33%	20%	67%
Shares Outstanding (Diluted)	106.08	95.9	95.48	94.19	40.93	36.19
Shares Change (YoY)	10%	0%	1%	130%	13%	20%
EPS (Diluted)	-0.12	-0.13	-0.09	-0.08	-0.16	-0.14
EPS Growth	-2%	39%	13%	-49%	18%	18%
Free Cash Flow	-7	-9	-8	-7	-6	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-6	-7	-9	-8	-6	-4
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-6	-7	-9	-8	-6	-4
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are BioSyntech Inc's key financial statements?



According to the latest financial statement (Form-10K), BioSyntech Inc has a total asset of $7, Net loss of $-12

What are the key financial ratios for BSYI?



BioSyntech Inc's Current ratio is 0.53, has a Net margin is 0, sales per share of $0.

How is BioSyntech Inc's revenue broken down by segment or geography?



BioSyntech Inc largest revenue segment is Hygiene, at a revenue of 289,100,000 in the most earnings release.For geography, United Kingdom is the primary market for BioSyntech Inc, at a revenue of 179,600,000.

Is BioSyntech Inc profitable?



no, according to the latest financial statements, BioSyntech Inc has a net loss of $-12

Does BioSyntech Inc have any liabilities?



yes, BioSyntech Inc has liability of 13

How many outstanding shares for BioSyntech Inc?



BioSyntech Inc has a total outstanding shares of 101.31

BioSyntech Inc (BSYI) Financial

BSYI Stock Price Chart